Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com Related Posts Crypto Market Update: Coinbase Posts US$667 Million Q4 Loss February 14, 2026 Tech Weekly: AI “Scare Trade” Spills into New Sectors February 14, 2026 Top 5 Canadian Mining Stocks This Week: Trinity One Surges 105 Percent February 14, 2026